טוען...
Asthma-associated risk for COVID-19 development
The newly described severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for a pandemic (coronavirus disease 2019 [COVID-19]). It is now well established that certain comorbidities define high-risk patients. They include hypertension, diabetes, and coronary artery disease. In...
שמור ב:
| הוצא לאור ב: | J Allergy Clin Immunol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Academy of Allergy, Asthma & Immunology
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7834224/ https://ncbi.nlm.nih.gov/pubmed/33002516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2020.09.017 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|